Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database

被引：15

作者：

Dominguez-Valentin, Mev ^{[1
]}

Seppala, Toni T. ^{[2
,3
]}

Engel, Christoph ^{[4
]}

Aretz, Stefan ^{[5
,6
]}

Macrae, Finlay ^{[7
,8
]}

Winship, Ingrid ^{[7
,8
]}

Capella, Gabriel ^{[9
,10
]}

Thomas, Huw ^{[11
]}

Hovig, Eivind ^{[1
,12
]}

Nielsen, Maartje ^{[13
]}

Sijmons, Rolf H. ^{[14
]}

Bertario, Lucio ^{[15
]}

Bonanni, Bernardo ^{[16
]}

Tibiletti, Maria Grazia ^{[17
]}

Cavestro, Giulia Martina ^{[18
]}

Mints, Miriam ^{[19
]}

Gluck, Nathan ^{[20
,21
]}

Katz, Lior ^{[22
]}

Heinimann, Karl ^{[23
]}

Vaccaro, Carlos A. ^{[24
]}

Green, Kate ^{[25
,26
]}

Lalloo, Fiona ^{[25
,26
]}

Hill, James ^{[25
,27
]}

Schmiegel, Wolff ^{[28
]}

Vangala, Deepak ^{[29
]}

Perne, Claudia ^{[5
,6
]}

Strauss, Hans-Georg ^{[30
]}

Tecklenburg, Johanna ^{[31
]}

Holinski-Feder, Elke ^{[32
,33
]}

Steinke-Lange, Verena ^{[32
,33
]}

Mecklin, Jukka-Pekka ^{[34
,35
]}

Plazzer, John-Paul ^{[7
]}

Pineda, Marta ^{[9
,10
]}

Navarro, Matilde ^{[9
,10
]}

Vidal, Joan Brunet ^{[9
,10
]}

Kariv, Revital ^{[20
,21
]}

Rosner, Guy ^{[20
,21
]}

Alejandra Pinero, Tamara ^{[24
]}

Laura Gonzalez, Maria ^{[24
]}

Kalfayan, Pablo ^{[24
]}

Sampson, Julian R. ^{[36
]}

Ryan, Neil A. J. ^{[25
,26
]}

Evans, D. Gareth ^{[25
,26
]}

Moller, Pal ^{[1
]}

Crosbie, Emma J. ^{[25
,26
]}

机构：

[1] Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, N-0379 Oslo, Norway

[2] Univ Helsinki, Dept Abdominal Surg, Cent Hosp, Helsinki 00029, Finland

[3] Univ Helsinki, Fac Med, Helsinki 00014, Finland

[4] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04107 Leipzig, Germany

[5] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany

[6] Univ Hosp Bonn, Ctr Hereditary Tumor Syndromes, D-53127 Bonn, Germany

[7] Royal Melbourne Hosp, Colorectal Med & Genet, Melbourne, Vic 3052, Australia

[8] Univ Melbourne, Dept Med, Melbourne, Vic 3052, Australia

[9] Inst Invest Biomed Bellvitge IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, ONCOBELL Program, Barcelona 08908, Spain

[10] Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain

[11] Imperial Coll London, Dept Surg & Canc, St Marks Hosp, London HA1 3UJ, England

[12] Univ Oslo, Ctr Bioinformat, Dept Informat, N-0316 Oslo, Norway

[13] Leids Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands

[14] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 GZ Groningen, Netherlands

[15] Fdn IRCCS Ist Nazl Tumori, European Inst Oncol, Div Prevent & Genet Oncol, I-20141 Milan, Italy

[16] European Inst Oncol, Div Prevent & Genet Oncol, I-20141 Milan, Italy

[17] Univ Insubria, Osped Circolo ASST Settelaghi, Ctr Ric Tumori Eredo Familiari, I-21100 Varese, Italy

[18] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Gastroenterol & Gastrointestinal Endoscopy Unit, I-20132 Milan, Italy

[19] Karolinska Inst, S-17176 Stockholm, Sweden

[20] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol, IL-64239 Tel Aviv, Israel

[21] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel

[22] Hadassah Med Ctr, Dept Gastroenterol & Hepatol, IL-91120 Jerusalem, Israel

[23] Univ Hosp Basel, Inst Med Genet & Pathol, Med Genet, CH-4031 Basel, Switzerland

[24] Hosp Italiano Buenos Aires, Hereditary Canc Program PROCANHE, C1199ABB, Buenos Aires, DF, Argentina

[25] Univ Manchester, Manchester M13 9WL, Lancs, England

[26] Manchester Univ NHS Fdn Trust, Manchester M13 9WL, Lancs, England

[27] Manchester Univ NHS Fdn Trust, Dept Surg, Manchester M13 9WL, Lancs, England

[28] Ruhr Univ Bochum, Dept Med, Knappschaftskrankenhaus, D-44801 Bochum, Germany

[29] Ruhr Univ Bochum, Dept Med, Knappschaftskrankenhaus, D-44892 Bochum, Germany

[30] Martin Luther Univ Halle Wittenberg, Univ Clin, Dept Gynecol, D-06097 Halle, Saale, Germany

[31] Hannover Med Sch, Inst Human Genet, D-30625 Hannover, Germany

[32] Klinikum Univ Munchen, Med Klin & Poliklin 4, Campus Innenstadt, D-80336 Munich, Germany

[33] MGZ Med Genet Ctr, D-80335 Munich, Germany

[34] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla 40014, Finland

[35] Cent Finland Hlth Care Dist, Dept Surg, Jyvaskyla 40620, Finland

[36] Cardiff Univ, Sch Med, Div Canc & Genet, Inst Med Genet, Cardiff CF14 4XN, Wales

来源：

JOURNAL OF CLINICAL MEDICINE | 2020年 / 9卷 / 07期

关键词：

Lynch syndrome; endometrial cancer; ovarian cancer; risk-reducing surgery; HORMONE REPLACEMENT THERAPY; COLORECTAL-CANCER; HEALTH; ESTROGEN;

D O I：

10.3390/jcm9072290

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and advice regarding hormone replacement therapy (HRT) in women with Lynch syndrome. Methods: We conducted a survey in 31 contributing centers from the Prospective Lynch Syndrome Database (PLSD), which incorporates 18 countries worldwide. The survey covered local policies for risk-reducing hysterectomy and BSO in Lynch syndrome, the timing when these measures are offered, the involvement of stakeholders and advice regarding HRT. Results: Risk-reducing hysterectomy and BSO are offered to path_MLH1 and path_MSH2 carriers in 20/21 (95%) contributing centers, to path_MSH6 carriers in 19/21 (91%) and to path_PMS2 carriers in 14/21 (67%). Regarding the involvement of stakeholders, there is global agreement (similar to 90%) that risk-reducing surgery should be offered to women, and that this discussion may involve gynecologists, genetic counselors and/or medical geneticists. Prescription of estrogen-only HRT is offered by 15/21 (71%) centers to women of variable age range (35-55 years). Conclusions: Most centers offer risk-reducing gynecological surgery to carriers of path_MLH1, path_MSH2 and path_MSH6 variants but less so for path_PMS2 carriers. There is wide variation in how, when and to whom this is offered. The Manchester International Consensus Group developed recommendations to harmonize clinical practice across centers, but there is a clear need for more research.

引用

页码：1 / 8

页数：8

共 50 条

[1] Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium
Pål Møller
Toni Seppälä
James G. Dowty
Saskia Haupt
Mev Dominguez-Valentin
Lone Sunde
Inge Bernstein
Christoph Engel
Stefan Aretz
Maartje Nielsen
Gabriel Capella
Dafydd Gareth Evans
John Burn
Elke Holinski-Feder
Lucio Bertario
Bernardo Bonanni
Annika Lindblom
Zohar Levi
Finlay Macrae
Ingrid Winship
John-Paul Plazzer
Rolf Sijmons
Luigi Laghi
Adriana Della Valle
Karl Heinimann
Elizabeth Half
Francisco Lopez-Koestner
Karin Alvarez-Valenzuela
Rodney J. Scott
Lior Katz
Ido Laish
Elez Vainer
Carlos Alberto Vaccaro
Dirce Maria Carraro
Nathan Gluck
Naim Abu-Freha
Aine Stakelum
Rory Kennelly
Des Winter
Benedito Mauro Rossi
Marc Greenblatt
Mabel Bohorquez
Harsh Sheth
Maria Grazia Tibiletti
Leonardo S. Lino-Silva
Karoline Horisberger
Carmen Portenkirchner
Ivana Nascimento
Norma Teresa Rossi
Leandro Apolinário da Silva
Hereditary Cancer in Clinical Practice, 20
[2] Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium
Moller, Pal
Seppala, Toni
Dowty, James G.
Haupt, Saskia
Dominguez-Valentin, Mev
Sunde, Lone
Bernstein, Inge
Engel, Christoph
Aretz, Stefan
Nielsen, Maartje
Capella, Gabriel
Evans, Dafydd Gareth
Burn, John
Holinski-Feder, Elke
Bertario, Lucio
Bonanni, Bernardo
Lindblom, Annika
Levi, Zohar
Macrae, Finlay
Winship, Ingrid
Plazzer, John-Paul
Sijmons, Rolf
Laghi, Luigi
Della Valle, Adriana
Heinimann, Karl
Half, Elizabeth
Lopez-Koestner, Francisco
Alvarez-Valenzuela, Karin
Scott, Rodney J.
Katz, Lior
Laish, Ido
Vainer, Elez
Vaccaro, Carlos Alberto
Carraro, Dirce Maria
Gluck, Nathan
Abu-Freha, Naim
Stakelum, Aine
Kennelly, Rory
Winter, Des
Rossi, Benedito Mauro
Greenblatt, Marc
Bohorquez, Mabel
Sheth, Harsh
Tibiletti, Maria Grazia
Lino-Silva, Leonardo S.
Horisberger, Karoline
Portenkirchner, Carmen
Nascimento, Ivana
Rossi, Norma Teresa
da Silva, Leandro Apolinario
HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
[3] Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals
Duenas, Nuria
Navarro, Matilde
Teule, Alex
Solanes, Ares
Salinas, Monica
Iglesias, Silvia
Munte, Elisabet
Ponce, Jordi
Guardiola, Jordi
Kreisler, Esther
Carballas, Elvira
Cuadrado, Marta
Matias-Guiu, Xavier
de la Ossa, Napoleon
Lop, Joan
Lazaro, Conxi
Capella, Gabriel
Pineda, Marta
Brunet, Joan
CANCERS, 2020, 12 (11) : 1 - 17
[4] Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer (Review)
Adachi, Masataka
Banno, Kouji
Yanokura, Megumi
Lida, Miho
Nakamura, Kanako
Nogami, Yuya
Umene, Kiyoko
Masuda, Kenta
Kisu, Iori
Ueki, Arisa
Hirasawa, Akira
Tominaga, Eiichiro
Aoki, Daisuke
MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 267 - 273
[5] The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome
Moldovan, Ramona
Keating, Sianan
Clancy, Tara
FAMILIAL CANCER, 2015, 14 (01) : 51 - 60
[6] The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome
Ramona Moldovan
Sianan Keating
Tara Clancy
Familial Cancer, 2015, 14 : 51 - 60
[7] An evaluation of the use of screening and risk-reducing surgery for gynaecological cancer in lynch syndrome: A review
Lim, N.
Macrae, F.
Hickey, M.
Kelly, C.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 61 - 61
[8] Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers
Eikenboom, Ellis L.
van Doorn, Helena C.
Dinjens, Winand N. M.
Dubbink, Hendrikus J.
Geurts-Giele, Willemina R. R.
Spaander, Manon C. W.
Tops, Carli M. J.
Wagner, Anja
Goverde, Anne
CANCERS, 2021, 13 (03) : 1 - 16
[9] Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)
Seppala, Toni T.
Dominguez-Valentin, Mev
Sampson, Julian R.
Moller, Pal
FAMILIAL CANCER, 2021, 20 (01) : 35 - 39
[10] Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)
Toni T. Seppälä
Mev Dominguez-Valentin
Julian R. Sampson
Pål Møller
Familial Cancer, 2021, 20 : 35 - 39

← 1 2 3 4 5 →